Skip to main content

Maximum Strength Adult Cough plus Chest Congestion DM

NDC 55319-740 · FAMILY DOLLAR SERVICES INC

Generic nameDextromethorphan HBr, Guaifenesin
Dosage formSOLUTION
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 400 mg/20mL; mg/20mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

55319-740-04 — 1 BOTTLE in 1 CARTON (55319-740-04) / 118 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55319-551 — Guaifenesin, 55319-628 — ACETAMINOPHEN,DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL, 55319-641 — Acetaminophen Dextromethorphan HBr Doxylamine Succinate Phenylephrine HCI, 55319-646 — Acetaminophen Dextromethorphan HBr Phenylephrine HCl, 55319-689 — Chlorpheniramine maleate, Dextromethorphan HBr, 55319-692 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 55319-705 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 55319-731 — Dextromethorphan HBr, Guaifenesin, 55319-733 — Guaifenesin, 55319-734 — Guaifenesin, Dextromethorphan HBr, 55319-741 — Guaifenesin, Dextromethorphan HBr, 55319-754 — chlorpheniramine maleate, dextrometrorphan HBr, 55319-815 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 55319-890 — Dextromethorphan Hydrobromide / Guaifenesin, 55319-891 — Guaifenesin, 55319-924 — Dextromethorphan HBr, Guaifenesin, 55319-926 — Acetaminophen, Dextromethorphan Hydrobromide and Doxylamine succinate, 55319-933 — ACETAMINOPHEN, DEXTROMETHORPHAN, PHENYLEPHRINE HCL, 55319-934 — ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL, 55319-954 — Acetaminophen Dextromethorphan HBr, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.